Cargando…
Case report: Denosumab-associated acute heart failure in patients with cardiorenal insufficiency
Denosumab is a pivotal treatment for postmenopausal women with osteoporosis. Although its clinical use is generally well tolerated by patients, denosumab in patients with renal insufficiency may increase the risk of hypocalcemia. Thus, we have to consider the population of denosumab in the treatment...
Autores principales: | Xing, Yuexian, Ju, Sicong, Sun, Mengyu, Xiang, Shoukui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515392/ https://www.ncbi.nlm.nih.gov/pubmed/36187135 http://dx.doi.org/10.3389/fendo.2022.970571 |
Ejemplares similares
-
Cardiorenal benefits of finerenone: protecting kidney and heart
por: González-Juanatey, José R., et al.
Publicado: (2023) -
Cardiorenal biomarkers in acute heart failure
por: Choudhary, Rajiv, et al.
Publicado: (2012) -
Cardiorenal Syndrome in Acute Heart Failure Syndromes
por: Sarraf, Mohammad, et al.
Publicado: (2011) -
Denosumab for the Treatment of Hypercalcemia in a Patient With Parathyroid Carcinoma: A Case Report
por: Roukain, Abdallah, et al.
Publicado: (2022) -
A Case of Acute Decompensated Heart Failure Complicated by Cardiorenal Syndrome Treated With Ultrafiltration
por: Mandal, Gaurav, et al.
Publicado: (2022)